Press Releases

Opthea To Present at SVB Leerink Global Healthcare Conference

February 10, 2022

Read More

Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference

February 9, 2022

Read More

Opthea Announces Establishment of At-The-Market Equity Program

February 1, 2022

Read More

Opthea Receives A$6.6 m R&D Tax Incentive

January 24, 2022

Read More

Opthea To Present at H.C. Wainwright BIOCONNECT Virtual Conference

January 4, 2022

Read More

Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet AMD

January 3, 2022

Read More

Opthea Granted Chinese Patent Covering OPT-302

October 26, 2021

Read More

Opthea Opens Patient Enrollment in the Asia-Pacific Region for the OPT-302 ShORe and COAST Phase 3 Trials in Wet AMD

October 19, 2021

Read More

Opthea Chairman's Address to the 2021 Annual General Meeting

October 19, 2021

Read More

Opthea Opens Patient Recruitment in Europe for Pivotal Phase 3 ShORe and COAST Wet AMD Trials of OPT-302

October 4, 2021

Read More